please share with your colleagues.

Listening to KZbin podcasts is a great way for continuous medical education. Thanks. Please share the "EM Note" channel with your friends.

Glad it was helpful! Please share with your colleagues.

You're welcome. Please share with your friends. 😊😊

Any time! Please share the channel with your friends.

Thanks. And please share with your colleagues.

haha. Just some stock footages. Sorry for the improperly used background visuals.

😇

Welcome to the channel.

Yes. Antivenin in severe cases.

Rare but crucial.

Nice tips. Thanks

Good question. I have no clue.

Prepare for ICU. Cases are usually immunocompromised.

Hope you don't run into one. 😁😁

Thank you! Please share with your colleagues?

Hahaha. Agree 😂😅😂😁😊

Here is a concise response addressing your questions about recognizing and managing tumor lysis syndrome (TLS): Tumor lysis syndrome is characterized by rapid development of hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia, which can lead to acute kidney injury and other life-threatening complications. Patients at highest risk include those with bulky, rapidly proliferating tumors that are sensitive to treatment, such as acute leukemias and high-grade lymphomas. Clinicians should monitor high-risk patients closely by checking serum levels of uric acid, potassium, phosphorus, and calcium at baseline and frequently (e.g. daily) during and after initiation of cancer treatment. Spontaneous TLS can also occur, so monitoring is important even before treatment starts. Symptoms like nausea, vomiting, fatigue, and decreased urine output may indicate developing TLS, especially in the first week after starting cancer therapy. Prompt recognition and management are critical, as TLS can rapidly progress to organ failure and death. In addition to managing hyperkalemia and hyperuricemia, other key early interventions include aggressive intravenous hydration, phosphate binders, and close monitoring of electrolytes and renal function. Patients at high risk may also receive prophylactic medications like allopurinol or rasburicase.

Lecture: Tumor Lysis Syndrome. kzbin.info/www/bejne/oHSkkohqistreLM

​@@jackcfchongThank you. Please keep up the excellent work.

Should go to ER ASAP. The lethal dose of phenobarbital is between 6-10 grams. Activated charcoal may be prescribed.

Necrotizing enterocolitis (NEC) is a serious gastrointestinal condition that primarily affects premature infants. The key treatments include stopping feedings and providing intravenous fluids and nutrition to allow the intestines to rest and heal, administering broad-spectrum antibiotics to treat potential infections, providing respiratory and cardiovascular support if the infant's condition deteriorates, performing surgery to remove damaged intestinal tissue or repair perforations in severe cases, and transitioning back to feedings, preferably with breast milk, once the infant's condition improves.

Correct🎉🎉

I will try my best. Thanks.

Please share with your colleagues.

Welcome. Please share with your colleagues.

OK, I'll try my best.

Thanks 😍😍😍

Didn't work for me

Yes

Sorry to hear that. Take care.

Yes. Correct answer is C.